Advancing Principled Pharmacoepidemiologic Research to Support Regulatory and Healthcare Decision Making: The Era of Real-World Evidence

Pharmacoepidemiology lacked a consolidated framework articulating the methodological, regulatory, and technological factors driving the evolution of real-world evidence as a credible input to healthcare decision-making.

Target RWE's scientific leadership co-authored a landmark review in Clinical Pharmacology & Therapeutics synthesizing the four forces driving the RWE era: rich healthcare data, advanced extraction technologies, principled causal inference methods, and global regulatory guidance.

Establishing a rigorous intellectual framework for principled pharmacoepidemiology positions Target RWE as a thought leader shaping how regulators, payers, and clinicians evaluate RWE.

Thought leadership establishing principled pharmacoepidemiology framework for regulatory RWE acceptance, Scientific positioning of Target RWE as a leader in causal inference-based evidence generation